Dissecting TDP-43 toxicity with novel FTD/ALS iPSC models

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two clinically different neurodegenerative diseases that lie on a pathogenic spectrum. The most common pathology present in ALS and FTD cases is cytoplasmic mislocalisation and aggregation of...

GABAergic mechanisms in people at clinical high risk for psychosis

Background: Abnormalities of the neurotransmitter system GABA are consistent findings in post-mortem and preclinical studies in psychosis. GABAergic abnormalities have been linked to not only psychotic symptoms but also cognitive deficits that are not treated...

Autism and Functional Neurological Disorders

Functional Neurological Disorders (FNDs) are common causes of neurological symptoms such as seizures, limb weakness, movement disorders and sensory changes without structural neuropathology. There is increasing evidence of an association with autism in both adults and...

Remote assessment of disease flares in rheumatoid arthritis

There has been an increasing interest in the potential of remote assessment technologies in healthcare settings (e.g., electronic patient reported outcomes [ePROs]) to allow additional information to inform decision making. Until the Covid-19 pandemic these...

Developing a neuroprogression-based staging model of anorexia nervosa

Background: Anorexia nervosa (AN) is a serious psychiatric condition with the highest mortality rate of any psychiatric illness. The factors that perpetuate and maintain the illness remain elusive and in particular, understanding surrounding the neurobiology of AN is...

Photosensitivity in Epilepsy: A failure of Adaptation?

Epilepsy is the most common and highest impact neurological disorder and there are no medical cures because the pathophysiological brain mechanisms are poorly understood. The condition arises from excitation-inhibition imbalance in neocortical networks, with...